The Indian government has published new rules for the medical technology sector that will put an end to the current practice of regulating medical devices and in vitro diagnostics as drug products when they come into effect on Jan. 1, 2018.
The new rules are based on the international risk-based approach. Both multinational and domestic medtech manufacturers operating in India have welcomed the development, but they say there are several issues...